For decades, the WABC newscaster encouraged other families facing the disease to hold onto hope. Now, he finds himself ...
The FDA is allowing MMI to enroll more patients in a feasibility trial studying use of the Symani robot for microsurgery to ...
The 76-year-old journalist went public with his diagnosis last month, saying his first symptom was “forgetting people’s names ...
"SuperAgers" keep razor-sharp memories past 80, but a new study shows this is not just down to good genes.
Laredo dementia specialist Jose Angel Hernandez wrote a children's book to help families discuss Alzheimer's disease with ...
Bipartisan legislation would require insurers to cover FDA-approved medications that significantly slow disease progression, ...
People who lived within 50 km of a coal-fired power plant were 72.9% more likely to develop Alzheimer’s disease pathology ...
ABC 7 New York on MSN
Alzheimer's research: Columbia doctors pinpoint where the disease begins
Bill Ritter spoke with doctors at Columbia about Alzheimer's disease and their groundbreaking research.
New studies point to the power of testing for and treating tau, a protein that builds up in Alzheimer’s disease, instead of just amyloid.
Rather than target amyloid plaques, the potential new treatment aims to restore immune functions that naturally decline with age.
Despite recent drug developments and other medical gains, Alzheimer’s disease is not going away — and neither are efforts to ...
With so many unknowns, Biogen is carefully eyeing its next-gen Alzheimer’s treatment diranersen as a high-risk, high-reward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results